N
NXL
Nexalin Tech
0.3321
+0.0015+0.45%After Hours: 0.3486 +0.0165 +4.97%19:05 08/21 EDT
OPEN/PREV CLOSE0.3325/0.3306
TODAY RANGE0.3275-0.3326
VOL88.65K
MARKET CAP7.32M
52 WEEK RANGE0.3050-2.000
AVG VOL (3M)294.43K
% TURNOVER0.32%
TURNOVER--
P/E (TTM)-0.7113
% RANGE1.39%
EPS(TTM)-0.4669
P/E(FORWARD)-0.8739
P/B4.806
BVPS0.0691
DIVIDEND--
P/S21.15
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP6.55M
SHARES OUTSTANDING22.04M
NEXT EARNINGS11/12-11/16
FREE FLOAT19.72M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·18h ago
Nexalin Technology Raises Liquidity via Short-Term Note
TipRanks·1d ago
Nexalin Announces Capital Raise and Flexible Equity Facility
TipRanks·5d ago
Nexalin Faces New Nasdaq Equity Deficiency, Delisting Risk
TipRanks·07/29 21:49
Nexalin Expands and Extends Houston Headquarters Lease Commitment
Benzinga·07/28 12:05
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
TipRanks·07/27 21:50
Nexalin Appeals Nasdaq Delisting Following Compliance Shortfalls
Benzinga·07/21 21:05
12 Health Care Stocks Moving In Tuesday's After-Market Session
Benzinga·07/17 21:05
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga·07/13 12:05
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga·07/08 12:05
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
TipRanks·06/23 15:25
Nexalin Technology investigator wins award for neurostimulation research
TipRanks·06/17 22:57
Nexalin Overhauls Bylaws, Modernizes Corporate Governance Framework
TipRanks·06/10 13:32
Nexalin Technology completes neurostimulation protocol trial